Push To Lift Medicare Ban On Obesity Drugs Grabs Attention At Republican Convention

At The Republican Convention, Drug Maker Lobbies For More Coverage Of Obesity Drugs

The main hall at the Republican National Convention has been ringing all week with talk about terrorism, immigration, and national security. But in a side venue on Wednesday, a small crowd gathered to talk about a more intimate topic: Obesity. Pharma giant Novo Nordisk co-sponsored the “Rethink Obesity” panel here, and plans to co-host a similar event during the Democratic convention next week in Philadelphia. The goal: To push lawmakers to enact a bill, pending in Congress, that would lift a longstanding ban on Medicare paying for obesity medication. (Keshavan, 7/21)